-4%
Ufol is prescribed for:
- Inducing and maintaining general anesthesia
- Providing sedation in intensive care settings
- Sedation for surgical and diagnostic procedures
Note: This medication should be taken only as directed by a registered physician.
Ufol is a short-acting, highly lipid-soluble intravenous anesthetic. It typically induces anesthesia within 30-60 seconds, with patients regaining consciousness quickly, often without confusion or nausea. Most individuals become fully alert within minutes and are ready for discharge after a few hours. Unlike many other anesthetic agents, Ufol does not accumulate significantly in the body with continued use, making it suitable for prolonged sedation in intensive care.
Its pharmacokinetics follow a three-phase distribution model:
- Rapid distribution from blood to tissues (half-life: 2-3 minutes)
- Quick metabolic elimination from blood (half-life: 30-60 minutes)
- Slow final phase, where the drug is cleared from poorly perfused tissues
Due to its lipid solubility, Ufol readily crosses the blood-brain barrier, directly affecting the central nervous system. Its duration of anesthesia is directly related to the dosage and blood concentration. The liver metabolizes Ufol into inactive glucuronide and sulfate conjugates, which are excreted through urine.
